Get started
Author

Valentina Menesello

Observed names: Menesello, Valentina, V. Menesello
ORCID: 0000-0002-8414-2203
Observed ORCID: 0000-0002-8414-2203
OpenAlex ID: A5065645153
Biological markers of sex-based differences in major depressive disorder and in antidepressant response
2023 · Rosana Carvalho Silva, Claudia Pisanu, et al. · European Neuropsychopharmacology · 57
The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers
2022 · Alessandra Minelli, Rosana Carvalho Silva, et al. · Brain Sciences · 41
PDF
DNA methylation changes in association with trauma-focused psychotherapy efficacy in treatment-resistant depression patients: a prospective longitudinal study
2024 · Rosana Carvalho Silva, Paolo Martini, et al. · European Journal of Psychotraumatology · 35
Everything changes but nothing changes: gender stereotypes in the Italian population
2024 · Rosana Carvalho Silva, Marika Vezzoli, et al. · Archives of Women s Mental Health · 20
PDF
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study
2024 · Rosana Carvalho Silva, Paolo Martini, et al. · Clinical Epigenetics · 15
Blood transcriptomic analysis reveals a distinct molecular subtype of treatment resistant depression compared to non-treatment resistant depression
2025 · Anna Sirés, Jorge Domínguez-Barragán, et al. · Brain Behavior and Immunity · 11
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response
2024 · Bernhard T. Baune, Alessandra Minelli, et al. · Frontiers in Psychiatry · 10
PDF
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients
2025 · Chiara Galbiati, Vincenzo Dattilo, et al. · Journal of Ect · 7
Leukocyte Telomere Length and Mitochondrial DNA Copy Number in Treatment-Resistant Depression and Response to Electroconvulsive Therapy: A Pilot Longitudinal Study
2024 · Alessio Squassina, Claudia Pisanu, et al. · Journal of Ect · 6
Symptom profiles at baseline are associated with remission in major depression: a confirmatory analysis of the PANDORA trial
2026 · Maria Luca, Alessandro Serretti, et al. · Journal of Psychiatric Research · 5
Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a real-world clinical setting
2025 · Alessandra Minelli, Stefano Barlati, et al. · European Psychiatry · 5
PDF
Agitation and anxiety features define a more severe phenotype in unipolar depression
2025 · Maria Luca, Antonina Luca, et al. · Psychiatry Research · 4
Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch
2025 · Alessandro Serretti, Stefano Barlati, et al. · Journal of Affective Disorders · 4
Methylation changes in association with early life stress and trauma-focused psychotherapy in treatment-resistant depression
2023 · R. Carvalho Silva, C. Hohoff, et al. · European Psychiatry · 4
PDF
Association between childhood neglect and psychiatric disorders in adults: systematic review, meta-analysis and meta-regression
2026 · Mariagrazia Merola, Sara Carletto, et al. · The British Journal of Psychiatry · 2
PDF
Integrating Genetic Variants and Expression Profiles of Pharmacogenes to Investigate Resistance to Antidepressant Treatment
2026 · Claudia Pisanu, Alessio Squassina, et al. · Medicina · 1
Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression: findings from a large cross-sectional European survey
2025 · Viktor T. H. Wahner, Johannes C. S. Zang, et al. · Frontiers in Psychiatry · 1
PDF
Clinical correlates of complete versus partial remission in major depressive disorder: an exploratory analysis of three cohorts
2026 · Alessandro Serretti, Alessandra Minelli, et al. · European Neuropsychopharmacology
PDF
Polygenic liability for major depression, schizophrenia and bipolar disorder and treatment outcome across major psychiatric disorders
2026 · Alessandro Serretti, Daniel Souery, et al. · medRxiv
PDF
Reply to Letter to the Editor: Methodological considerations regarding confirmatory claims and multiple comparisons in the PANDORA trial symptom-remission analysis
2026 · Maria Luca, Alessandro Serretti, et al. · Journal of Psychiatric Research
Association between childhood neglect and psychiatric disorders in adults: systematic review, meta-analysis and meta-regression – ERRATUM
2026 · Mariagrazia Merola, Sara Carletto, et al. · The British Journal of Psychiatry
PDF
Mild motor signs in major depressive disorder: prevalence and clinical profile
2026 · Antonina Luca, Alessandro Serretti, et al. · The European Journal of Psychiatry
Involvement of pharmacogenetic variants in antidepressant treatment outcomes
2024 · L. Buson, S. Bignotti, et al. · Neuroscience Applied
Utility of pharmacogenetic testing to optimise antidepressant treatment in major depressive disorder: preliminary data from a randomised controlled trial
2024 · V. Menesello, A. Minelli, et al. · Neuroscience Applied
Exome analysis on major depressive disorder patients to identify novel genetic variants associated with pharmacogenetic response
2024 · A. Magistrali, S. Bignotti, et al. · Neuroscience Applied
Works count: 33
Citation count: 237
H-index: 7
I10-index: 7
Year
Topic
Type